RT Journal Article
SR Electronic
A1 Cunningham, Muriel
T1 FUSION II: No Advantage for Serial Nesiritide Infusions
JF MD Conference Express
YR 2007
FD SAGE Publications
VO 7
IS 1
SP 16
OP 16
DO 10.1177/155989770700700107
UL http://mdc.sagepub.com/content/7/1/16.1.abstract
AB Outpatient infusions of nesiritide did not prolong survival or prevent future hospitalizations in patients with advanced chronic heart failure and a history of acute decompensation, according to the results of FUSION II, the first large, randomized, controlled study to test the efficacy of this regimen.